Acadia Healthcare Company, Inc.
ACHCNasdaqCIK 1520697HealthcareFiscal year ends Dec 31
Reports and events: 298 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2520:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031225 |
| 2026-07-2820:57 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-024693 |
| 2026-07-2820:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-321076 |
| 2026-05-1821:15 ET | 8-K | 8.01 Other events | 0001193125-26-229138 |
| 2026-05-0621:02 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-209324 |
| 2026-04-3022:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-192508 |
| 2026-04-2921:22 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-013916 |
| 2026-04-2320:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-173769 |
| 2026-03-2521:02 ET | DEF 14A | Proxy statementPeriod 2026-05-06 | 0001140361-26-011130 |
| 2026-03-1220:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-104272 |
| 2026-02-2700:52 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-078266 |
| 2026-02-2512:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-005431 |
| 2026-01-2317:47 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001539497-26-000135 |
| 2026-01-2313:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-020169 |
| 2026-01-2013:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-001486 |
| 2026-01-1313:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-001137 |
| 2025-12-0221:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-036657 |
| 2025-11-2400:22 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001539497-25-003053 |
| 2025-11-1021:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-274380 |
| 2025-11-0521:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-267062 |
| 2025-11-0521:11 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-033347 |
| 2025-10-0720:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-233507 |
| 2025-10-0120:01 ET | SCHEDULE 13D | Ownership report, active investor | 0001539497-25-002580 |
| 2025-09-2911:05 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-221545 |
| 2025-08-0520:45 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103160 |
| 2025-08-0520:33 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-024875 |
| 2025-05-3020:31 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-132208 |
| 2025-05-1220:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016141 |
| 2025-05-1220:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069294 |
| 2025-04-1021:02 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001140361-25-013294 |
| 2025-03-1021:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-051083 |
| 2025-02-2821:36 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-042573 |
| 2025-02-2721:25 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029095 |
| 2025-02-2721:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-005467 |
| 2025-01-1313:02 ET | 8-K | 2.02 Results of operations | 0001193125-25-005003 |
| 2024-10-3021:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-032658 |
| 2024-10-3020:31 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-119044 |
| 2024-09-2712:30 ET | 8-K | 8.01 Other events | 0001193125-24-227393 |
| 2024-08-0120:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-089248 |
| 2024-07-3121:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-024148 |
| 2024-05-2413:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-146576 |
| 2024-05-0220:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052085 |
| 2024-05-0121:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-014205 |
| 2024-04-0921:02 ET | DEF 14A | Proxy statementPeriod 2024-05-23 | 0001140361-24-018895 |
| 2024-02-2821:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-022057 |
| 2024-02-2722:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-005735 |
| 2024-01-1921:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-011225 |
| 2023-11-0320:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058814 |
| 2023-11-0221:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001637 |
| 2023-10-3020:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-266248 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.